Sign in
IGAP Stock Price, Chart, Stats & News
GlucoTrack, Inc.
Save
50.23M
Market cap
–
Current P/E
–
Forward P/E
IGAP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | 82.05% |
ROE | 120.82% |
D/E | 0.01x |
Interest coverage ratio | – |
IGAP valuation
P/E | – |
P/S | – |
P/B | 1.06x |
P/CF | -0.99x |
P/FCF | -17.04x |
P/OCF | -0.99x |
PEG | 0.00x |
EV multiple | – |
About
GlucoTrack, Inc., established in 2001 and headquartered in Or Yehuda, Israel, is a medical technology enterprise. The company specializes in the research, engineering, and market introduction of non-invasive glucose monitoring apparatus. Its flagship product, the GlucoTrack device, provides a pain-free method for individuals managing diabetes or pre-diabetes to track their blood glucose concentrations.
Similar securities
Based on sector and market capitalization
Report issue